Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2019-11-15
2025-01-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BBD Longitudinal Study of Osteogenesis Imperfecta
NCT02432625
Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation
NCT03575221
Pregnancy in Osteogenesis Imperfecta (OI) Registry
NCT03072303
Study of Osteogenesis Imperfecta Tendon
NCT06065111
Urinary Biomarkers of OI Pathobiology
NCT02531087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim of the study: In this observational study, we intend to evaluate the feasibility of non-invasive cuff blood pressure monitoring in a select group of patients with OI in the inpatient postoperative period.
Materials and Methods Following Nemours IRB approval and consent from the parent or legal guardian, fifty children with OI scheduled for lower extremity surgery with subsequent in-hospital admission will be enrolled in the study. Since we performed preformed lower extremity surgeries on thirty patients in each of the past two years, we anticipate the study will take two years to complete.
A group of registered nurses would be educated about the study and equipment used, review of appropriate blood pressure cuff size selection, blood pressure monitoring protocol, signs and symptoms of adverse events, and steps to take if an adverse event occurred.
Inclusion Criteria:
* Patients with OI who are undergoing extremity surgery or spinal fusion surgery.
* Patients between the ages of 1 and 35 years with OI who are admitted at our institution to a non-ICU inpatient setting in the postoperative period following an orthopedic surgery.
* Patients who initially require ICU-level care but transition to a non-ICU setting following an orthopedic surgery.
* Recent fracture in contralateral upper extremity (\< 8 weeks, or upper extremity fracture that is not yet completely healed).
* Must be able to tolerate upper extremity blood pressures.
* Medical clearance by OI physicians (Kruse, Franzone) after review of fracture history, surgical procedures, x-rays.
Exclusion Criteria:
* Parent or child refusal, uncooperative child.
* History of frequent upper extremity fracture on ipsilateral side, or recent upper extremity fracture on ipsilateral side if only that side may be used.
* Clinical presence of thrombocytopenia (excessive or easy bleeding or bruising), admission or transfer to PICU.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OI manual cuff BP
Patients with diagnosis of Osteogenesis Imperfecta from ages 1 to 35 who are admitted to our institution to the inpatient, non-ICU setting, following orthopedic surgery for spine surgery, upper or lower extremity realignment and IM rodding
Manual cuff blood pressure
Blood pressure will be obtained using a sphygmomanometer. Only Registered Nurses will apply BP cuff after careful inspection of the upper extremity for bruising, swelling or tenderness.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual cuff blood pressure
Blood pressure will be obtained using a sphygmomanometer. Only Registered Nurses will apply BP cuff after careful inspection of the upper extremity for bruising, swelling or tenderness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients between the ages of 1 and 35 years with OI who are admitted at our institution to a non-ICU inpatient setting in the postoperative period following an orthopedic surgery.
* Patients who initially require ICU-level care but transition to a non-ICU setting following an orthopedic surgery.
* Recent fracture in contralateral upper extremity (\< 8 weeks, or upper extremity fracture that is not yet completely healed).
* Must be able to tolerate upper extremity blood pressures.
* Medical clearance by OI physicians (Kruse, Franzone) after review of fracture history, surgical procedures, x-rays.
Exclusion Criteria
* History of frequent upper extremity fracture on ipsilateral side, or recent upper extremity fracture on ipsilateral side if only that side may be used.
* Clinical presence of thrombocytopenia (excessive or easy bleeding or bruising), admission or transfer to PICU.
1 Year
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nemours Children's Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alicia McCarthy
Nurse Practitioner
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alicia McCarthy, MSN
Role: PRINCIPAL_INVESTIGATOR
Nemours Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nemours / A I duPont Hospital for Children
Wilmington, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1465218-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.